Gary Nabel

Dr. Gary J.
Nabel is an Independent Director at Candel Therapeutics, Inc., a Director & Chief Innovation Officer at OPKO Health, Inc., an Independent Director at SIGA Technologies, Inc. and a President & Chief Executive Officer at ModeX Therapeutics, Inc. He is on the Board of Directors at Candel Therapeutics, Inc., OPKO Health, Inc. and SIGA Technologies, Inc. Dr. Nabel was previously employed as a Chief Scientific Officer & Senior Vice President by Sanofi, a Director-Vaccine Research Center by National Institutes of Health, and a Chairman by Keystone Symposia.
He received his undergraduate degree from Harvard College, a doctorate degree from Harvard University and a doctorate degree from Harvard Medical School.